AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for the healthcare companies.
AMRI president and CEO Thomas D’Ambra said that they believe that combining all of their discovery capabilities in biology and discovery chemistry under the direction of Sargent will further enhance AMRI’s ability to generate significant value for our customers and stakeholders.